Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2024;35(1):172-8
Article Links
Late-Presenting Eosinophilic Granulomatosis with Polyangiitis as Cause of Pulmonary Fibrosis: A Case-Based Review
Juan Felipe Coronado-Sarmiento1, Juan Pablo Coronado-López2, Eduardo Tuta-Quintero1, Claudia Marcela Mora1,3, Viviana Mayor2,4
Authors Information

1Faculty of Medicine, Universidad de la Sabana, Chia, Colombia

2Health Sciences Faculty, Pontificia Universidad Javeriana, Cali, Colombia

3Internal Medicine Department, Universidad de la Sabana, Chia, Colombia

4Internal Medicine Department, Universidad del Bosque, Bogota, Colombia

JF Coronado-Sarmiento, JP Coronado-López, E Tuta-Quintero, CM Mora, V Mayor

Keywords: eosinophilic granulomatous vasculitis, ANCA-associated vasculitis, pulmonary fibrosis, interstitial pneumonia
References
  1. Nguyen Y, Guillevin L. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss). Semin Respir Crit Care Med 2018 Aug;39(4):471-81. https://doi.org/10.1055/s-0038-1669454 
  2. Mohammad AJ. An update on the epidemiology of ANCA-associated vasculitis. Rheumatol (United Kingdom) 2020;59:iii42–50. https://doi.org/10.1093/rheumatology/keaa089
  3. Trivioli G, Terrier B, Vaglio A. Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management. Rheumatology (Oxford) 2020 May 1;59(Suppl 3):iii84-iii94. https://doi.org/10.1093/rheumatology/kez570 
  4. Geetha D, Jefferson JA. ANCA-Associated Vasculitis: Core Curriculum 2020. Am J Kidney Dis 2020 Jan;75(1):124-37. doi: 10.1053/j.ajkd.2019.04.031. https://doi.org/10.1053/j.ajkd.2019.04.031 
  5. Streho M, Sable-Fourtassou R, Brion MC, Bourotte I, Valeyre D, Brauner M, et al. Churg-Strauss syndrome and pulmonary fibrosis: An unusual association | Syndrome de Churg-Strauss et fibrose pulmonaire: Une association exceptionnelle. Press Medicale 2006;35(9 I). https://doi.org/10.1016/s0755-4982(06)74799-6 
  6. Qiao L, Med B, Gao D. A case report and literature review of Churg-Strauss syndrome presenting with myocarditis. Med (United States) 2016;95(51):e5080. https://doi.org/10.1097/MD.0000000000005080 
  7. Berti A, Boukhlal S, Groh M, Cornec D. Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease. Expert Rev Clin Immunol [Internet] 2020;16(1):51–61. https://doi.org/10.1080/1744666X.2019.1697678 
  8. Asano K, Ueki S, Tamari M, Imoto Y, Fujieda S, Taniguchi M. Adult-onset eosinophilic airway diseases. Allergy Eur J Allergy Clin Immunol 2020;75(12):3087–99. https://doi.org/10.1111/all.14620
  9. Domínguez-Quintana M, Alba MA, Hinojosa-Azaola A. Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype. Rheumatol Int [Internet] 2021;41(10):1717–28. https://doi.org/10.1007/s00296-021-04966-5 
  10. Dąbrowska D, Jabłońska E, Garley M, Ratajczak-Wrona W, Iwaniuk A. New Aspects of the Biology of Neutrophil Extracellular Traps. Scand J Immunol 2016;84(6):317–22. https://doi.org/10.1111/sji.12494 
  11. Negreros M, Flores-Suárez LF. A proposed role of neutrophil extracellular traps and their interplay with fibroblasts in ANCA-associated vasculitis lung fibrosis. Autoimmun Rev 2021;20(4). https://doi.org/10.1016/j.autrev.2021.102781
  12. Chakraborty RK, Aeddula NR. Churg Strauss Syndrome [Internet]. Vol. 42, StatPearls 2022. 1–18 p. PMID: 30725784
  13. Sebastiani M, Manfredi A, Vacchi C, Cassone G, Faverio P, Cavazza A, et al. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis. Clin Exp Rheumatol 2020;38(2):221–31. PMID: 32324122.
  14. Homma S, Suzuki A, Sato K. Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist. Clin Exp Nephrol 2013;17(5):667–71. https://doi.org/10.1007/s10157-012-0710-7 
  15. Koike H, Nishi R, Ohyama K, Morozumi S, Kawagashira Y, Furukawa S, et al. ANCA-Associated Vasculitic Neuropathies: A Review. Neurol Ther [Internet] 2022; https://doi.org/10.1007/s40120-021-00315-7
  16. André R, Cottin V, Saraux JL, Blaison G, Bienvenu B, Cathebras P, et al. Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature. Autoimmun Rev [Internet] 2017;16(9):963–9. http://dx.doi.org/10.1016/j.autrev.2017.07.007 
  17. Moosig F, Holle J. Current treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Z Rheumatol 2019;78(4):333–8. https://doi.org/10.1007/s00393-018-0580-9 
  18. Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 2016;75(9):1583–94. http://dx.doi.org/10.1136/annrheumdis-2016-209133
  1. Raffray L, Guillevin L. Updates for the treatment of EGPA. Press Medicale [Internet] 2020;49(3):104036. https://doi.org/10.1016/j.lpm.2020.104036
  2. Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Arthritis Care Res (Hoboken) [Internet] 2021 Aug 8;73(8):1088–105. https://onlinelibrary.wiley.com/doi/10.1002/acr.24634
  3. Sokołowska B, Szczeklik W, Piłat O, Wodkowski M, Pieczątka J, Gąsior J, et al. The impact of current health-related quality of life on future health outlook in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Clin Rheumatol 2013;32:779–85. https://doi.org/10.1007/s10067-013-2169-7